Maternal–fetal transport kinetics of carboplatin in the perfused human placental lobule: In vitro study

References

• Jamieson E R, Lippard S J. Structure, recognition and processing of cisplatin–DNA adducts. Chem Rev 1999; 99: 2467–2498
   PubMed Web of Science ®Google Scholar
• Reedijk J. New clues for platinum antitumor chemistry: Kinetically controlled metal binding to DNA. Proc Natl Acad Sci USA 2003; 100: 3611–3616
   PubMed Web of Science ®Google Scholar
• Hogberg T, Glimelius B, Nygren P. A systematic overview of chemotherapy effects in ovarian cancer. Acta Oncol 2001; 40: 340–360
   PubMedGoogle Scholar
• Alberts D S, Dorr R T. New perspectives on an old friend: Optimizing carboplatin for the treatment of solid tumors. Oncologist 1998; 3: 1–36
   PubMedGoogle Scholar
• Go R S, Adjei A A. Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. J Clin Oncol 1999; 17: 409–422
   PubMed Web of Science ®Google Scholar
• Perez E A. Carboplatin in combination therapy for metastatic breast cancer. Oncologist 2004; 6: 518–527
   Google Scholar
• Kolaric K, Vukas D. Carboplatin activity in untreated metastatic breast cancer patients—results of a phase II study. Cancer Chemother Pharmacol 1991; 27: 409–412
   PubMed Web of Science ®Google Scholar
• Young R C. Gynecologic malignancies. Cancer Chemother Biol Response Modif 1987; 9: 303–337
   PubMedGoogle Scholar
• De Andres Basauri L, Lopez Pousa A, Alba E, Sampedro F. Carboplatin, an active drug in advanced head and neck cancer. Cancer Treat Rep 1986; 70: 1173–1176
   PubMedGoogle Scholar
• Martin J, Ginsberg R J, Venkatraman E S, Bains M S, Downey R J, Korst R J, Kris M G, Risch V W. Long-term results of combined-modality therapy in resectable non-small-cell lung cancer. J Clin Oncol 2002; 20: 1989–1995
   PubMed Web of Science ®Google Scholar
• Keresztes R S, Prot J L, Pasmantier M W, Korst R J, Altorki N K. Preoperative chemotherapy for esophageal cancer with paclitaxel and carboplatin. J Thorac Cardiovasc Surg 2003; 126: 1603–1608
   PubMed Web of Science ®Google Scholar
• Casper E S, Bajorin D. Phase II trial of carboplatin in patients with advanced melanoma. Invest New Drugs 1990; 8: 187–190
   PubMed Web of Science ®Google Scholar
• Suzuki K, Usami T, Sudoko H, Ohtawara Y, Tajima A, Kawabe K, Aso Y. Experimental study on carboplatin toxicity—a comparison with cisplatin. Gan T Kagaku Ryoho 1988; 15: 2153–2158
   PubMedGoogle Scholar
• Watanabe W, Kuwabara R, Nakahara T, Hamasaki O, Sakamoto I, Okada K, Minamoto A, Mishima H K. Severe ocular and orbital toxicity after intracarotid injection of carboplatin for recurrent glioblastomas. Graefes Arch Clin Exp Opthalmol 2002; 240: 1033–1035
   PubMed Web of Science ®Google Scholar
• Kai S, Kohmura H, Ishikawa K, Makihara Y, Ohta S, Kawano S, Takahashi N. Teratogenic effects of carboplatin, an oncostatic drug, administered during the early organogenetic period in rats. J Toxicol Sci 1989; 14: 115–130
   PubMedGoogle Scholar
• Ferrandina G, Distefano M, Testa A, De Vincenzo R, Scambia G. Management of an advanced ovarian cancer at 15 weeks of gestation: Case report and literature review. Gynecol Oncol 2005; 97: 693–696
   PubMed Web of Science ®Google Scholar
• Adolph A, Le T, Khan K, Biem S. Recurrent metastatic fallopian tube carcinoma in pregnancy. Gynecol Oncol 2001; 81: 110–112
   PubMedGoogle Scholar
• Hoekstra A V, Keh P, Lurain J R. Placental site trophoblastic tumor: A review of 7 cases and their implications for prognosis and treatment. J Reprod Med 2004; 49: 447–452
   PubMedGoogle Scholar
• Nandakumaran M, Gardey C, Challier J C, Panigel M, Olive G. Transfer of salbutamol in the human placenta in vitro. Dev Pharmacol Ther 1981; 3: 88–98
   PubMedGoogle Scholar
• Nandakumaran M, Makhseed M, al-Rayyes S, al-Yatama M, Devarajan L, Sugathan T. Kinetics of palmitic acid transport in insulin-dependent diabetic pregnancies: In vitro study. Pediatr Int 2000; 42: 296–301
   PubMed Web of Science ®Google Scholar
• Nandakumaran M, Makhseed M, Al-Rayyes S, Akanji A O, Sugathan T N. Effect of insulin on transport kinetics of alpha-aminoisobutyric acid in the perfused human placental lobule in vitro. Pediatr Int 2001; 43: 581–586
   PubMed Web of Science ®Google Scholar
• Schneider H, Proegler M, Sodha R, Dancis J. Asymmetrical transfer of alpha-aminoisobutyric acid (AIB), leucine and lysine across the in vitro perfused human placenta. Placenta 1985; 8: 141–151
   Google Scholar
• Nandakumaran M, Sugathan T N. Assessment of transport dynamics in the perfused human placental lobule. Med Princ Pract 1992–93; 3: 219–222
   Google Scholar
• El-Yazigi A, Al-Saleh I. Rapid determination of platinum in plasma by flameless atomic absorption spectrophotometry following the administration of cisplatin to cancer patients. Ther Drug Monit 1986; 8: 318–320
   PubMed Web of Science ®Google Scholar
• Brodie B B, Axelrod J, Soberman R. The estimation of antipyrine in biological materials. J Biol Chem 1949; 179: 25–29
   PubMed Web of Science ®Google Scholar
• Rey E, Nandakumaran M, Richard M O, Loose J P, D'Athis P, Saint Maurice C, Olive G. Pharmacokinetics of flunitrazepam after single rectal administration in children. Dev Pharmacol Ther 1984; 7(Suppl 1)206–212
   PubMedGoogle Scholar
• Nandakumaran M, Eldeen A S. Transfer of cyclosporine A in the perfused human placenta. Dev Pharmacol Ther 1990; 15: 101–105
   PubMedGoogle Scholar
• Challier J C, Guerre-Millo M, Richard M O, Schneider H, Panigel M, Olive G. Transfert et echange d'antipyrine dans le lobule placentaire humain perfuse in vitro. Ann Biol Anim Biochim Biophys 1977; 17: 1107–1115
   Google Scholar
• Schneider H, Panigel M, Dancis J. Transfer across the perfused human placenta of antipyrine, sodium and leucine. Am J Obstet Gynecol 1972; 114: 822–828
   PubMed Web of Science ®Google Scholar
• Battaglia F C, Meschia G, Makowski E L. Comparison of in vitro and in vivo placental permeability measurements. Am J Physiol 1969; 216: 1590–1594
   PubMedGoogle Scholar
• Seeds A E, Schruefer J J, Reinhardt J A, Garlid K D. Diffusion mechanism across human placental tissue. Gynecol Invest 1973; 4: 31–37
   PubMedGoogle Scholar
• Koc O N, McFee M, Reed E, Gerson S L. Detection of platinum–DNA adducts in cord blood lymphocytes following in utero platinum exposure. Eur J Cancer 1994; 30A: 716–717
   PubMed Web of Science ®Google Scholar
• Moya F, Thorndike V. Passage of drugs across the placenta. Am J Obstet Gynecol 1962; 84: 1778–1798
   PubMed Web of Science ®Google Scholar
• Nandakumaran M, Challier J C, Rey E, Richard M O, Olive G. In vitro transfer of six benzamides in the human placenta. Dev Pharmacol Ther 1984; 7: 60–66
   PubMedGoogle Scholar
• Nandakumaran M, Olive G. Placental transfer of drugs: A mini-review. Recent trends in perinatology, N N Roy Chowdhury, J Roy Chowdhury. Nachiketa, CalcuttaIndia 1983; 141–178
   Google Scholar
• Screnci D, McKeage M J, Galettis P, Hambley T W, Palmer B D, Baguley B C. Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs. Br J Cancer 2000; 82: 966–972
   PubMed Web of Science ®Google Scholar
• Kumagai T, Inoue T, Mihara Y, Ebina K, Yokota K. Influence of drugs on the oxygen uptake rate and biosorption of activated sludge. Biol Pharm Bull 2006; 29: 183–186
   PubMedGoogle Scholar
• Boisdron-Celle M, Lebouil A, Gamelin E. Pharmacokinetic properties of platinum derivatives. Bull Cancer 2001; 88: 14–19
   PubMed Web of Science ®Google Scholar
• Nandakumaran M, Gardey C, Challier J C, Rey E, Lambrey B, Olive G. Transfer of salbutamol, ritodrine and norepinephrine in the human placenta. Pharmacologie du developpement, H Mathieu, G Olive, H Pontonnier. INSERM, Paris, Paris 1979; 86: 255–264
   Google Scholar
• Ferrandina G, Distefano M, Testa A, De Vincenzo R, Scambia G. Management of an advanced ovarian cancer at 15 weeks gestation: Case report and literature review. Gynecol Oncol 2005; 97: 693–696
   PubMed Web of Science ®Google Scholar
• Mendez L E, Mueller A, Salom E, Gonzalez-Quintero V H. Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer. Gynecol Oncol 2003; 102: 1200–1202
   Google Scholar
• Shamkhani H, Anderson L M, Henderson C E, Moskal T J, Runowicz C D, Dove L F, Jones A B, Cahney S G, Rice J M, Poirier M C. DNA adducts in human and patas monkey maternal and fetal tissues induced by platinum drug chemotherapy. Reprod Toxicol 1994; 8: 207–216
   PubMed Web of Science ®Google Scholar
• Mulvihill A, Budning A, Jay V, Vandenhoven C, Heon E, Gallie B L, Chan H S. Ocular motility changes after subtenon carboplatin chemotherapy for retinoblastoma. Arch Ophthalmol 2005; 123: 128–129
   PubMedGoogle Scholar
• Vadhan-Raj S, Kudelka A P, Garrison L, Gano J, Edwards C L, Freedman R S, Cavanagh J J. Effects of interleukin-1 on carboplatin-induced thrombocytopenia in patients with recurrent ovarian cancer. J Clin Oncol 1994; 12: 707–714
   PubMed Web of Science ®Google Scholar
• Kearns C M, Egorin M J. Considerations regarding the less-than-expected thrombocytopenia encountered with combination paclitaxel/carboplatin chemotherapy. Semin Oncol 1997; 24: S291–S296
   Google Scholar
• Reed I, Jacob J. Carboplatin and renal dysfunction. Ann Intern Med 1989; 110: 409–412
   PubMedGoogle Scholar